Not "worst advice ever". I wouldn't call the following dreaming:
- strong preclinical data,
- world first Human trial soon to start using Allogeneic IPSC-derived MSC's
- Fujifilm acquires 9% of CYP and has all the resources to do due diligence
CYP needs to expand visibility whilst they move towards revenues and other milestones
DYOR
Fuji knows better, page-7
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $45.80M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 25.5¢ | $10.03K | 38.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27654 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 14.08pm 17/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |